tiprankstipranks
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Income Statement

Compare
1,231 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q4 2024), Madrigal Pharmaceuticals's total revenue was $103.32M, an increase of 13318.18% from the same quarter last year. In Q4, Madrigal Pharmaceuticals's net income was $-59.42M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 180.13M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 173.90M$ -527.00K$ -467.00K$ -405.00K$ -471.00K
Operating Expenses
$ 671.77M$ 380.50M$ 293.57M$ 242.48M$ 206.67M
Depreciation and Amortization
$ 1.10M$ 527.00K$ 467.00K$ 405.00K$ 471.00K
EBITDA
$ -450.13M$ -379.97M$ -293.10M$ -242.08M$ -206.20M
Operating Income
$ -497.88M$ -380.50M$ -293.57M$ -242.48M$ -206.67M
Other Income/Expenses
$ 31.98M$ 6.87M$ -1.78M$ 636.00K$ 4.43M
Pretax Income
$ -465.89M$ -373.63M$ -295.35M$ -241.85M$ -202.24M
Net Income
$ -465.89M$ -373.63M$ -299.31M$ -241.08M$ -197.44M
Per Share Metrics
Basic EPS
$ -21.90$ -19.99$ -17.47$ -14.58$ -12.78
Diluted EPS
$ -21.90$ -19.99$ -17.47$ -14.58$ -12.78
Weighted Average Shares Outstanding
21.27M 18.69M 17.14M 16.54M 15.45M
Weighted Average Shares Outstanding (Diluted)
21.27M 18.69M 17.14M 16.54M 15.45M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis